Goodwill of Keenova Therapeutics plc from 28 Sep 2012 to 26 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Keenova Therapeutics plc quarterly Goodwill in USD history and change rate from 28 Sep 2012 to 26 Sep 2025.
  • Keenova Therapeutics plc Goodwill for the quarter ending 26 Sep 2025 was $7,300,000.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Keenova Therapeutics plc Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $7,300,000 26 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q4 2024 $0 27 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q4 2018 $0 -$3,482,700,000 -100% 28 Dec 2018 10-K 26 Feb 2019 2018 FY
Q3 2018 $3,675,400,000 +$215,900,000 +6.2% 28 Sep 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 $3,676,700,000 +$230,500,000 +6.7% 29 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 $3,674,000,000 +$227,800,000 +6.6% 30 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 $3,482,700,000 -$15,400,000 -0.44% 29 Dec 2017 10-K 26 Feb 2019 2018 FY
Q3 2017 $3,459,500,000 -$245,800,000 -6.6% 29 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 $3,446,200,000 -$199,300,000 -5.5% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 $3,446,200,000 -$199,100,000 -5.5% 31 Mar 2017 10-Q 08 May 2017 2017 Q1
Q4 2016 $3,498,100,000 -$147,100,000 -4% 30 Dec 2016 10-K 27 Feb 2018 2017 FY
Q3 2016 $3,705,300,000 +$55,900,000 +1.5% 30 Sep 2016 10-QT 07 Feb 2017 2016 Q4
Q2 2016 $3,645,500,000 +$411,500,000 +13% 24 Jun 2016 10-Q 02 Aug 2016 2016 Q3
Q1 2016 $3,645,300,000 +$1,219,200,000 +50% 25 Mar 2016 10-Q 03 May 2016 2016 Q2
Q4 2015 $3,645,200,000 +$1,231,500,000 +51% 25 Dec 2015 10-Q 02 Feb 2016 2016 Q1
Q3 2015 $3,649,400,000 +$1,247,500,000 +52% 25 Sep 2015 10-K 29 Nov 2016 2016 FY
Q2 2015 $3,234,000,000 +$2,379,800,000 +279% 26 Jun 2015 10-Q 04 Aug 2015 2015 Q3
Q1 2015 $2,426,100,000 +$1,572,200,000 +184% 27 Mar 2015 10-Q 05 May 2015 2015 Q2
Q4 2014 $2,413,700,000 +$1,881,700,000 +354% 26 Dec 2014 10-Q 03 Feb 2015 2015 Q1
Q3 2014 $2,401,900,000 +$1,869,900,000 +351% 26 Sep 2014 10-K 24 Nov 2015 2015 FY
Q2 2014 $854,200,000 +$322,200,000 +61% 27 Jun 2014 10-Q 07 Aug 2014 2014 Q3
Q1 2014 $853,900,000 28 Mar 2014 10-Q 08 May 2014 2014 Q2
Q4 2013 $532,000,000 27 Dec 2013 10-Q 07 Feb 2014 2014 Q1
Q3 2013 $532,000,000 +$24,500,000 +4.8% 27 Sep 2013 8-K 03 Apr 2015 2014 FY
Q2 2013 $532,000,000 28 Jun 2013 10-Q 12 Aug 2013 2013 Q3
Q3 2012 $507,500,000 28 Sep 2012 10-K 13 Dec 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.